GD2-specific CAR T cell therapies for pediatric solid cancers

被引：0
|
作者：
Rossig, Claudia
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PEDIATRIC24-IA015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA015
引用
收藏
页数：2
相关论文
共 50 条
  • [31] GD2-SPECIFIC T CELLS EFFICIENTLY TARGET EWING SARCOMA CELLS IN VITRO AND IN VIVO
    Kailayangiri, Sareetha
    Altvater, Bianca
    Meltzer, Jutta
    Pscherer, Sibylle
    Luecke, Andrea
    Dierkes, Christian
    Leuchte, Katharina
    Hotfilder, Marc
    Dirksen, Uta
    Hardes, Jendrik
    Gosheger, Georg
    Juergens, Heribert
    Rossig, Claudia
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 710 - 711
  • [32] T-CELLS GRAFTED WITH GD2-SPECIFIC ANTITUMOUR ACTIVITY: DEVELOPMENT OF IMMUNOTHERAPY FOR NEUROBLASTOMA
    Straathof, Karin
    Kokalaki, Evangelia
    Philip, Brian
    Himoudi, Nourredine
    Pule, Martin
    Anderson, John
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1006 - 1006
  • [33] Prospects and challenges for use of CAR T cell therapies in solid tumors
    Ramakrishna, Sneha
    Barsan, Valentin
    Mackall, Crystal
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (05) : 503 - 516
  • [34] Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy
    Kaczanowska, Sabina
    Murty, Tara
    Alimadadi, Ahmad
    Contreras, Cristina F.
    Duault, Caroline
    Subrahmanyam, Priyanka B.
    Reynolds, Warren
    Gutierrez, Norma A.
    Baskar, Reema
    Wu, Catherine J.
    Michor, Franziska
    Altreuter, Jennifer
    Liu, Yang
    Jhaveri, Aashna
    Duong, Vandon
    Anbunathan, Hima
    Ong, Claire
    Zhang, Hua
    Moravec, Radim
    Yu, Joyce
    Biswas, Roshni
    Nostrand, Stephen Van
    Lindsay, James
    Pichavant, Mina
    Sotillo, Elena
    Bernstein, Donna
    Carbonell, Amanda
    Derdak, Joanne
    Klicka-Skeels, Jacquelyn
    Segal, Julia E.
    Dombi, Eva
    Harmon, Stephanie A.
    Turkbey, Baris
    Sahaf, Bita
    Bendall, Sean
    Maecker, Holden
    Highfill, Steven L.
    Stroncek, David
    Glod, John
    Merchant, Melinda
    Hedrick, Catherine C.
    Mackall, Crystal L.
    Ramakrishna, Sneha
    Kaplan, Rosandra N.
    CANCER CELL, 2024, 42 (01) : 35 - 51.e8
  • [35] Desmoglein 2 is a safe and universal CAR-T cell therapy target in solid cancers
    Carlson, R. D.
    Waldman, S. A.
    Mahoney, M. G.
    Snook, A. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S183 - S183
  • [36] Neutralization of murine myeloid suppressor cells enhances the efficacy of GD2-specific CAR T cells directed against human sarcoma in a xenograft model
    Highfill, Steven
    Smith, Jillian
    Long, Adrienne
    Cui, Yongzhi
    Orentas, Rimas
    Mackail, Crystal
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [37] A promising approach of GD2-specific chimeric antigen receptor (CAR) T cells with CD28/4.1BB costimulatory domains for treatment of GD2+sarcomas
    De Angelis, B.
    Camera, A.
    Orlando, D.
    Guercio, M.
    Sinibaldi, M.
    Cembrola, B. M.
    Caruso, S.
    Abbaszadeh, Z.
    Bovetti, K.
    Milano, G. M.
    Russo, I.
    De Vito, R.
    Quintarelli, C.
    Locatelli, F.
    HUMAN GENE THERAPY, 2019, 30 (11) : A69 - A70
  • [38] Myeloid cell rebound associated with GD2-CAR-T cell therapy in solid tumor patients
    Brown, Michael P.
    Gargett, Tessa
    Truong, Nga T.
    Vittorio, Orazio
    Ziegler, David S.
    CANCER RESEARCH, 2024, 84 (06)
  • [39] Involvement of Actin Filaments in the Cytotoxic Effect of GD2-Specific Antibodies
    Doronin, I. I.
    Kholodenko, I. V.
    Zubareva, A. A.
    Yarygin, K. N.
    Deev, S. M.
    Kholodenko, R. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2019, 166 (04) : 541 - 547
  • [40] Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma
    Liu, Zhuohao
    Zhou, Jiayi
    Yang, Xinzhi
    Liu, Yuchen
    Zou, Chang
    Lv, Wen
    Chen, Cheng
    Cheng, Kenneth King-yip
    Chen, Tao
    Chang, Lung-Ji
    Wu, Dinglan
    Mao, Jie
    MOLECULAR CANCER, 2023, 22 (01)
12345